Hematology/Oncology

Top Story

Patients with advanced cancer prefer face-to-face consultations

Patients with advanced cancer prefer face-to-face consultations
October 23, 2017

Nearly three-quarters of patients with advanced cancer preferred doctors who communicated with them face-to-face while holding a notepad rather than repeatedly using a computer, according to the results of a randomized controlled study scheduled for presentation at the Palliative and Supportive Care in Oncology Symposium.

“Our research highlights a very important aspect of doctor-patient communication: how cancer patients perceive their doctors when they use an examination room computer during visits,” Ali Haider, MD, assistant professor of palliative, rehabilitation and integrative medicine at The University of Texas MD Anderson Cancer Center, said during a press conference. “Because patients with cancer often experience high physical and psychosocial symptoms, it is very important for doctors to monitor certain physical cues to gain knowledge about their patients’ well-being.”

HPV vaccination vital for children, adolescents to prevent adult disease

October 23, 2017
This week, researchers reported that one out of nine adult men in the U.S.
Meeting News

Treatment based on BRCA1 expression levels fails to improve non-small cell lung cancer outcomes

October 23, 2017
Receipt of chemotherapy based on mRNA BRCA1 expression level failed to improve survival among node-positive patients with stage II and stage III non-small cell lung…

WHO’s Tedros rescinds appointment of Mugabe as ‘goodwill ambassador’

October 23, 2017
Amid widespread concern, WHO Director-General Tedros Adhanom Ghebreyesus, PhD, MSc, rescinded his appointment of Zimbabwe President Robert Mugabe as a “goodwill…
Meeting News

Fruquintinib, gefitinib shows promise for EGFR-mutated non-small cell lung cancer

October 23, 2017
The combination of fruquintinib with gefitinib appeared safe and effective for the first-line treatment of patients with non-small cell lung cancer and EGFR activating…
More Headlines »
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News

VIDEO: Gene alterations predict response to immunotherapy in urothelial carcinoma

September 13, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement